Merck (MRK) Dividends Paid - Common Growth (3y) (2012 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Div. Paid (Common) Growth (3y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
15.02% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
2.10% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
5.06% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
4.34% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
6.10% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
2.39% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
2.01% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
2.37% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
4.34% |
| Dec 31, 2025 |
4.86% |
| Sep 30, 2025 |
5.15% |
| Jun 30, 2025 |
5.48% |
| Mar 31, 2025 |
5.52% |
| Dec 31, 2024 |
5.89% |
| Sep 30, 2024 |
5.80% |
| Jun 30, 2024 |
5.88% |
| Mar 31, 2024 |
5.83% |
| Dec 31, 2023 |
6.30% |
| Sep 30, 2023 |
6.28% |
| Jun 30, 2023 |
6.13% |
| Mar 31, 2023 |
6.11% |
| Dec 31, 2022 |
7.59% |
| Sep 30, 2022 |
7.81% |
| Jun 30, 2022 |
6.43% |
| Mar 31, 2022 |
6.91% |
| Dec 31, 2021 |
8.76% |
| Sep 30, 2021 |
8.67% |
| Jun 30, 2021 |
8.47% |
| Mar 31, 2021 |
8.19% |
| Dec 31, 2020 |
6.32% |
| Sep 30, 2020 |
6.39% |
| Jun 30, 2020 |
6.46% |
| Mar 31, 2020 |
6.22% |
| Dec 31, 2019 |
3.40% |
| Sep 30, 2019 |
3.05% |
| Jun 30, 2019 |
4.13% |
| Mar 31, 2019 |
3.74% |
| Dec 31, 2018 |
0.37% |
| Sep 30, 2018 |
0.34% |
| Jun 30, 2018 |
0.23% |
| Mar 31, 2018 |
0.49% |
| Dec 31, 2017 |
0.63% |
| Sep 30, 2017 |
0.03% |
| Jun 30, 2017 |
-0.80% |
| Mar 31, 2017 |
0.10% |
| Dec 31, 2016 |
0.29% |
| Sep 30, 2016 |
0.40% |
| Jun 30, 2016 |
-0.81% |
| Mar 31, 2016 |
-0.69% |
| Dec 31, 2015 |
32.76% |
| Sep 30, 2015 |
-0.13% |
| Jun 30, 2015 |
0.57% |
| Mar 31, 2015 |
0.03% |
| Dec 31, 2014 |
33.32% |
| Sep 30, 2014 |
2.95% |
| Jun 30, 2014 |
4.42% |
| Mar 31, 2014 |
3.16% |
| Dec 31, 2013 |
33.26% |
| Sep 30, 2013 |
2.15% |
| Jun 30, 2013 |
3.86% |
| Mar 31, 2013 |
3.18% |
| Dec 31, 2012 |
-87.77% |
| Sep 30, 2012 |
16.68% |
| Jun 30, 2012 |
16.80% |
| Mar 31, 2012 |
16.76% |
